5alpha-Hydroxy laxogenin(CAS: 56786-63-1)

CAS Number
Related Products
2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
CAS Number: 34620-78-5
Ganoderic acid LM2
CAS Number: 508182-41-0
Other Suppliers for 5alpha-Hydroxy laxogenin
Basic Information
Molecular Formula
C27H42O5
Molecular Weight
446.63 g/mol
Physical Properties
Melting Point
268-270 ºC (ethanol )
Density
1.21±0.1 g/cm3 (20 ºC 760 Torr),
Chemical Identifiers
SMILES
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(=O)C6(C5(CCC(C6)O)C)O)C)C)OC1
InChIKey
HCRGPOQBVFMZFY-PPCFKNSFSA-N
Database References
MDL Number
MFCD00273330
FAQ
5alpha-Hydroxy laxogenin is a natural compound with the CAS number 56786-63-1. It is a flavonoid found in various plants, particularly in the genus Cirsium. The compound has a molecular formula of C15H12O4 and is characterized by its hydroxy group at the 5α position.
5alpha-Hydroxy laxogenin is primarily used in the pharmaceutical industry for its potential anti-inflammatory and anti-oxidant properties. It is also studied for its potential applications in food supplements due to its health benefits.
5alpha-Hydroxy laxogenin is generally considered safe for oral consumption in therapeutic doses. However, like any compound, it should be handled with care. Toxicity studies are limited, and precautionary measures are advised, especially in high concentrations or prolonged use.
5alpha-Hydroxy laxogenin should be stored in a cool, dry place away from direct sunlight to ensure stability. Keep the compound in a tightly sealed container to prevent degradation. The optimal storage temperature should be between 15-25°C (59-77°F).
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures


![4-{(1R,3aS,4R,6aS)-4-[4-(beta-D-Glucopyranosyloxy)-3,5-dimethoxyphenyl]tetrahydro-1H,3H-furo[3,4-c]furan-1-yl}-2,6-dimethoxyphenyl beta-D-glucopyranoside](https://static.chemtradehub.com/structs/667/66791-77-3-74b7.webp)


![2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol](https://static.chemtradehub.com/structs/346/34620-78-5-d616.webp)

![2-(3,4-Dihydroxy-5-methoxyphenyl)-5-(beta-D-glucopyranosyloxy)-7-hydroxy-3-chromeniumyl 6-O-{6-deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-alpha-L-mannopyranosyl}-beta-D-glucopyranoside chloride](https://static.chemtradehub.com/structs/699/69915-09-9-afab.webp)




